SGLT2 inhibitors: Real-world data show benefits outweigh risksApril 3, 2023DiabetesEndocrinologyNephrology
Living kidney donors should receive money for their costs of donatingMarch 21, 2023NephrologyImmunology
Can SGLT2 inhibitors limit acute kidney injury in type 2 diabetes?March 10, 2023DiabetesCardiologyNephrology
Postpartum urinary retention: Intermittent catheterization may be bestFebruary 22, 2023Women's HealthNephrology
Fair access crucial for new diabetes/kidney disease drugs, say guidelinesJanuary 11, 2023NephrologyDiabetes
Dapagliflozin reduces hospitalizations in patients with CKDDecember 6, 2022NephrologyPreventive CareDiabetesCardiology
FDA alert: ‘Substantial’ hypocalcemia risk with denosumab use in dialysis patientsNovember 23, 2022EndocrinologyWomen's HealthMusculoskeletal DisordersNephrology
Promising new antibiotic emerges for treating UTIsNovember 8, 2022Infectious DiseasesNephrologyWomen's Health
Study sheds new light on RAS inhibitors’ role for advanced CKDNovember 7, 2022NephrologyCardiologyMixed Topics
Kidney function may help docs pick antiplatelet mix after strokeOctober 31, 2022NephrologyCardiologyPreventive CareNeurology
Goodbye ‘diabetes insipidus’, hello ‘AVP-D’ and ‘AVP-R’October 25, 2022DiabetesRare DiseasesNephrologyEndocrinology
